Open Access Repository

Lumiracoxib (Novartis)


Downloads per month over past year

Ding, C and Jones, G 2002 , 'Lumiracoxib (Novartis)' , IDrugs, vol. 5, no. 12 , pp. 1168-1172 .

lumiracoxib.pdf | Download (98kB)
Available under University of Tasmania Standard License.

| Preview


Lumiracoxib, an inhibitor of cyclooxygenase 2 (COX-2), is under development by Novartis for the potential treatment of osteoarthritis, rheumatoid arthritis and pain. By late December 2000, phase III trials had been initiated and were ongoing in December 2001.

Item Type: Article
Authors/Creators:Ding, C and Jones, G
Journal or Publication Title: IDrugs
ISSN: 1369-7056
Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page